Swanbridge Capital
  • Home
  • Our Story
  • Strategy
  • Portfolio
  • Team
  • News & Events
  • Contact
Select Page

Swanbridge Capital invests in IPaDiC

by stefan | Jul 20, 2018 | Blog

Rotterdam, July 20th, 2018 – IPaDiC, a private company that aims to develop an implantable insulin pump, announced today that it has secured funding for the first phase of development. The funding allows IPaDiC to develop and validate a prototype of the insulin pump,...

Recent Posts

  • IMMAGENE announces seed investment round to progress novel Immuno-Oncology therapeutics
  • Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital
  • Swanbridge invests in Pan Cancer T
  • Allero Therapeutics and Abbreos join forces to clinically develop COVID-19 program
  • Swanbridge Capital invests in Immagene

Recent Comments

    Archives

    • November 2021
    • October 2021
    • February 2021
    • November 2020
    • September 2020
    • October 2019
    • April 2019
    • December 2018
    • July 2018
    • December 2017
    • October 2017
    • December 2016

    Categories

    • Blog
    • Geen categorie

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    • Facebook
    • Twitter
    • Google
    • RSS

    Designed by Elegant Themes | Powered by WordPress